OmPGandaMD

Diabetes, Lipid Metabolism

Associate Professor of Medicine, Joslin Diabetes Center

Dr. Ganda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1 Joslin Pl
Boston, MA 02215
Phone+1 617-309-2645

Fax+1 617-309-2712

Brigham and Women's HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1973 - 1976
Boston VA Healthcare System (Brockton-West Roxbury)Residency, Internal Medicine, 1972 - 1973
Tufts Medical CenterInternship, Internal Medicine, 1971 - 1972
Sawai Man Singh Medical CollegeClass of 1966

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011, 2013
Diabetes Recognition Program National Committee for Quality Assurance, 2010-2013

PubMed

629 citations
American College of Endocrinology position statement on the insulin resistance syndrome.
Daniel Einhorn, Gerald M. Reaven, Rhoda H. Cobin, Earl S. Ford, Om P. Ganda
Endocrine Practice. 2003-10-01
223 citations
Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the diabetes control and compl...
Neil H. White, Wanjie Sun, Patricia A. Cleary, Ronald P. Danis, Matthew D. Davis
Archives of Ophthalmology. 2008-12-01
40 citations
Diabetes in ageing: pathways for developing the evidence base for clinical guidance
Medha Munshi, Graydon S. Meneilly, Leocadio Rodríguez-Mañas, Kelly L. Close, Paul R. Conlin
The Lancet. Diabetes & Endocrinology. 2020-10-01

Diabetes Part-2: Dr. Om Ganda on Long-Term Complications from Diabetes, Prevention, Tests, Medicines, Diet & ExerciseAugust 15th, 2024
What to Know About Diabetes and the Risk of Silent Heart AttacksNovember 4th, 2022
The American Journal of Managed Care® Launches ‘The Progression of Type 2 Diabetes and the Treatment Options to Manage It’June 4th, 2019

28 Week Clinical Trial Comparing HOE 902 Insulin W/ NPH Human InsulinNational Center For Research Resources1999–2000

member, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN 2015
member, 2011 AACE Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
member, American Association of Clinical Endocrinologists and American College of Endocrinology - Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan 2015